Liver abscesses secondary to Salmonella species are rarely described in the general population. We herein describe a case of a liver abscess caused by CTX-M-55-type extended-spectrum β-lactamase (ESBL)-producing Salmonella enteritidis, which has not been reported in the literature. A 54-year-old male was admitted due to a high fever and was clinically diagnosed with a liver abscess. Culture of the fluid from the liver abscess revealed CTX-M-55-type ESBL-producing S. enteritidis. Although the patient underwent percutaneous transhepatic abscess drainage and antibiotic therapy, he died one month later. It should be noted that liver abscesses are potentially fatal depending on the causative pathogen.
Introduction
Pyogenic liver abscess (PLA) is a rare but potentially lethal condition, with a reported incidence of 20 per 100,000 hospital admissions in the western population and a mortality rate of 6-14% (1) (2) (3) (4) (5) . Common causative pathogens are Escherichia coli, Klebsiella pneumoniae, Bacteroides species, Enterococci, streptococci, and staphylococci (1), but liver abscess occurring as a complication of Salmonella infection is very rare (6, 7) .
The extended-spectrum β-lactamase (ESBL) enzyme was first identified in the early 1980s. Since then, ESBL production has been identified worldwide in a number of different organisms, including K. pneumoniae, E. coli, Proteus mirabilis, and Salmonella species (8) (9) (10) (11) . ESBL-producing Salmonella species are rare but have increased worldwide due to the abuse of β-lactams; the reported prevalence in western Pacific nations is 3.4% (8, (12) (13) (14) . CTX-M-type β-lactamase is one of the most common ESBLs (15) . The present case is noteworthy because we were able to isolate ESBL-producing S. enteritidis from the patient's liver abscess fluid, which has not been reported previously.
Case Report
A 54-year-old Japanese man was referred to our hospital from a Chinese hospital following two weeks of high fever with chills despite treatment with several antibiotics including imipenem (dosage details unknown). The chief complaint on presentation to our department was severe fatigue. His urine culture in China had revealed no abnormality, and blood and stool cultures had not been performed. The patient had worked and lived in China for six months and had He denied freshwater swimming and stated that he had only consumed bottled water. He had been healthy prior to the trip, and his medical examination performed immediately before leaving for China was normal. His physical examination revealed a temperature of 39.0 and right upper quadrant tenderness. Laboratory test results included significant leukocytosis (29.3×10 3 /μL, neutrophils 82.0%) with an elevated C-reactive protein level (31.7 mg/dL). Liver function test values were also elevated: total bilirubin, 1.8 mg/dL; aspartate aminotransferase (AST), 172 IU/L; alanine aminotransferase (ALT), 214 IU/L; albumin, 2.0 g/dL; and alkaline phosphatase, 1,469 mg/dL.
His multidetector computed tomography (MDCT) scan revealed a mass in the right hepatic lobe measuring 13.0× 11.5×8.2 cm with ring-enhanced, well-defined margins, containing a monolocular, relatively uniform fluid component (Fig. 1) . The patient was diagnosed with a liver abscess, and intravenous administration of doripenem (1.5 g/day) was started. On the fourth day after admission, he underwent percutaneous transhepatic abscess drainage (PTAD), and a pigtail catheter was placed ( Fig. 2A) . A large quantity of brown, turbid, foul-smelling drainage fluid was collected (Fig. 2B ). An X-ray image obtained immediately prior to PTAD revealed gas formation in the abscess cavity (Fig. 3B) , which was not seen on the admission X-ray (Fig. 3A) . The culture of fluid collected from the liver abscess was inoculated on Salmonella-Shigella (SS) agar and incubated at 37 for 20 hours. The causative pathogen was revealed to be ESBL-producing S. enteritidis, which also grew in the blood cultures. ESBL production was confirmed by a double disc synergy test (BD Diagnostics Systems, Hunt Valley, USA) according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (M100-S22). In addition, the polymerase chain reaction (PCR) products amplified from the clinical isolates from the liver abscess were subjected to direct sequencing. The primer sequences are shown in Table 1 . These investigations demonstrated that the ESBL was encoded by blaCTX-M-55. The minimum inhibitory concentrations (MICs) were determined by the CLSI agar dilution method and revealed that the isolate was resistant to penicillins, monobactams, and cephalosporins, and suscepti- 
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Trimethoprim-sulfamethoxazole 40 ble to carbapenems (Table 2 ). Doripenem was continued. A second MDCT performed on day eight revealed that a very large cavity remained at the abscess site (Fig. 4) . At that time, 300 mL of fluid had been drained from the PTAD tube. The tube was exchanged for those with increasing diameters, ending with a final size of 18Fr. Despite these treatments, the patient's pleural effusion and liver subcapsular fluid level gradually increased, and oxygen administration became necessary to treat his labored breathing. The patient's condition gradually worsened, and death occurred one month after admission.
Discussion
CTX-M-type β-lactamase is one of the most common ESBLs (15) and was reported to be the predominant ESBL among Enterobacteriaceae isolates (16, 17) . Lewis et al. found that the most common CTX-M-type ESBL was CTX-M-15 in a U.S. health care system (San Antonio, USA) (16) . In their report, CTX-M enzymes increased in prevalence from 25% in 2000 to 70% in 2006 among the collected ESBL-producing isolates. CTX-M-55-producing Salmonella isolates have only been reported rarely (18, 19) . CTX-M-55 . Lee et al. also reported the isolation of CTX-M-55-type ESBL-producing Shigella sonnei from a patient who had traveled to China (26) . Most of these cases, including the current case, occurred in China, suggesting that CTX-M-55-producing Enterobacteriaceae are widely disseminated throughout the country. The present patient had not eaten meat or egg products for several days before admission and denied the ingestion of tap water during his stay in China. Moreover, he denied having any contact with any animals during that time and had no history of diarrhea or abdominal pain before admission. The source of infection in this case remains unknown. CTX-M-55 is a variant of the CTX-M-15, differing by a single amino acid substitution at position 80 (19, 27) . Yu et al. reported that two isolates harboring CTX-M-55 were highly resistant to cefotaxime and ceftazidime (MICs >256 μg/mL), which was similar to three CTX-M-15-producing isolates having MICs ranging from 32-128 μg/mL for ceftazidime and high resistance to cefotaxime (MIC >256 μg/ mL) (19) . These data are consistent with the MICs found for the infectious organism in the present case, which were 16 μg/mL for ceftazidime and >64 μg/mL for cefotaxime. Although carbapenems exhibited high antimicrobial activity against S. enterica in the present case, the intravenous administration of doripenem had little effect. It is possible that the transvenous route did not allow a sufficient amount of doripenem to reach the liver abscess cavity, or that this strain was not very sensitive to doripenem. In addition, insufficient drainage achieved with PTAD might have affected the patient's response to doripenem.
Gas-forming pyogenic liver abscesses (GFPLAs) are considered to be a very severe form of PLA, and they are associated with a high fatality rate despite aggressive management (28, 29) . K. pneumoniae is the most common pathogen responsible for the disease, whereas Salmonella-related GFPLA is uncommon (28, 29) . GFPLA is a condition characterized by the vigorous metabolism and growth of bacteria, and it is closely associated with diabetes mellitus (28) . The present patient did not have diabetes mellitus. Bacteria usually obtain their energy through the fermentation of glucose, which often leads to an accumulation of acids. Gasforming microorganisms produce formic hydrogenlyase, which converts formic acid to CO2 and H2. Accumulation is due to the increased production of gas, impaired transportation of gas, and equilibration between gases in the local tissue and the abscess (28, 29) . No evidence of gas accumulation was seen on the admission MDCT scan or X-ray in the present case, suggesting that gas formation began after admission. Gas-forming Salmonella infections of other organs have also been reported (30) .
In conclusion, we reported a case of liver abscess due to CTX-M-55-producing S. enteritidis in a Japanese patient who had spent six months in China. To our knowledge, this is the first report of a liver abscess caused by ESBLproducing S. enteritidis.
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